April March

Sharma, E. Kumar
June 2008
Business Today;6/1/2008, Vol. 17 Issue 11, p38
The article reports on the acquisitions made by Dr Reddy's Laboratories in April 2008. Dr Reddy's Laboratories announced its decision to acquire a portion of Dowpharma Small Molecules Business from Dow Chemical Co. in April 1, 2008. Two days later, the company revealed its takeover of Jet Generici Srl. On the last day of April, the company announced it acquisition of the manufacturing business and related facility of BASF SE.


Related Articles

  • Dr. Reddy's Buys Italian Marketing firm. Ramesh, Deepti // Chemical Week;4/14/2008, Vol. 170 Issue 12, p33 

    The article reports on the announcement made by pharmaceutical firm Dr. Reddy's Laboratories of Hyderabad, India that it has acquired Jet Generici Srl of Italy. Financial terms were not disclosed. The acquisition provides access to an essential product portfolio, a pipeline of registration...

  • Reddy-ly establishing a European presence.  // Pharmaceutical Technology Europe;May2008, Vol. 20 Issue 5, p9 

    The article focuses on the significance of the two European acquisitions of Dr. Reddy's Laboratories Ltd. to its generic pipeline and research and development (R&D) infrastructure. The author claims that the acquisitions could result in cheaper medicines produced by the pharmaceutical company....

  • World Briefs.  // Pharmaceutical Technology;Jun2008, Vol. 32 Issue 6, p22 

    The article offers world new briefs related to acquisition. Dr. Reddy's Laboratories Ltd. acquired Dow Chemical Co.'s Downpharma small molecules business and BASF AG's manufacturing facility. DSM Corp. agreed to acquire the Polymer Technology Group Inc. and is subject to regulate approval, which...

  • Dr. Reddy's to Buy Part of Dow's Pharma Business in the U.K. Ramesh, Deepti // Chemical Week;4/7/2008, Vol. 170 Issue 11, p15 

    The article reports on an agreement entered by pharmaceutical company Dr. Reddy's Laboratories with Dow Chemical to acquire a part of the Dowpharma Small Molecules business at its sites in Mirfield and Cambridge, England. The firms now await regulatory approval for the deal which is expected to...

  • Dr Reddy's acquires Dow's molecule biz.  // Chemical Business;Apr2008, Vol. 22 Issue 4, p86 

    The article focuses on a definitive agreement entered into by Dr. Reddy's Laboratories Ltd. with the Dow Chemical Co. to acquire a portion of Dowpharma Small Molecules business associated with its sites in Mirfield and Cambridge, England. The acquisition will include the relevant business,...

  • Big money is back. Chang, Joseph // ICIS Chemical Business;6/7/2010, Vol. 277 Issue 20, p28 

    The article focuses on the growing mergers and acquisitions in the global chemical industry. It reports that the equity firm Bain Capital LLC has agreed to buy Styron business of Dow Chemical Co. for 1.63 billion U.S. dollars. It informs that Leveraged Buyouts (LBOs) can also make a comeback. It...

  • Dr. Reddy's Laboratories Ltd. Desai, Suresh Thakur // Chemical Business;Apr98, Vol. 12 Issue 4, p41 

    Analyzes the performance of India-based Dr. Reddy's Laboratories Ltd. during 1996-1997. Income; Exports; Strategy of brand acquisitions; Sales; Collaboration agreement with Board of Radiation and Isotope Technology; Patent applications.

  • Dr Reddy's Inks commercialisation Deal with Hatchtech.  // eHEALTH;9/16/2015, p1 

    The article reports on the commercialization contract signed by pharmaceutical company Dr. Reddy's Laboratories Ltd. with Australian pharmaceutical company Hatchtech Pty. Ltd., for the development of an innovative prescription head lice product Xeglyze lotion.

  • Growing SAP market reshuffles. Lerner, Ivan // Chemical Market Reporter;3/13/2006, Vol. 269 Issue 10, p32 

    The article reports on the impact of the acquisition of Dow Chemical Co. by Degussa AG on the superabsorbent polymers (SAP) market. The purchase made the Degussa-Dow SAP merger 32 percent of the market, outpacing the once top dog BASF AG. Nippon Shokubai Co. has been moved to the third spot....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics